Mirror Biologics, Inc.
15 clinical trials · Sponsor
◉ Watch Mirror Biologics, Inc.
| Record | Firm | Date |
|---|---|---|
| Combined AlloStim+Anti-PD-L1 in 4L MSS Metastatic Colorectal Cancer (NCT06557278) | Mirror Biologics, Inc. | 2026-11-01 |
| Immunotherapy for Advanced Liver Cancer (NCT05033522) | Mirror Biologics, Inc. | 2023-08-01 |
| Immunotherapy for Third Line Metastatic Colorectal Cancer (NCT04444622) | Mirror Biologics, Inc. | 2021-07-12 |
| Universal Anti-Viral Vaccine for Healthy Elderly Adults (NCT04441047) | Mirror Biologics, Inc. | 2021-07-12 |
| AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer (NCT01741038) | Mirror Biologics, Inc. | 2017-12-01 |
Track Mirror Biologics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.